India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to the deaths of children in India and also in countries including Gambia and Uzbekistan
· 10/30/2026, 4:44:00 PM· 2 min read
India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to the deaths of children in India and also in countries including Gambia and Uzbekistan
Read original story →Related stories
business
IRDAI upgrades business analytics platform for health covers
business
IGL net profit plummets 93% on higher input gas cost and consumer price protection
business
Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth
business